Lysosomal membrane protein LAPTM5: implications for nervous system pathology
Lysosomal dysfunction is implicated in the pathogenesis of various neurological disorders. LAPTM5, a lysosomal membrane protein, participates in the regulation of lysosomal function, autophagy, and immune responses. Emerging evidence suggests that LAPTM5 exerts context-dependent effects across different neurological diseases. LAPTM5 protects against cerebral ischemia/reperfusion injury but contributes to secondary brain injury following intracerebral hemorrhage. It is also associated with neuroinflammatory processes in Alzheimer's disease and neuropathic pain, although causal evidence remains limited in certain contexts. In neuroblastoma, LAPTM5 promotes lysosome-mediated tumor cell death, whereas its functions in glioma appear to depend on tumor subtype and molecular context. This review summarizes the molecular characteristics and regulatory mechanisms of LAPTM5, examines its diverse roles in neurological and nervous system-related disorders, and discusses its potential as a biomarker and therapeutic target. We also highlight current research limitations and future directions, emphasizing the need for multi-omics approaches and cell-type-specific functional studies to clarify the mechanisms of LAPTM5 and support its clinical translation.
Authors
- Dongqiong Xiao (ORCID: https://orcid.org/0000-0001-5536-4301)
- Lingli Pan
- Qian Zhang
Institutions
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
- Chengdu Women's and Children's Central Hospital (CN)
Publication Details
- Journal
- Cell Biology and Toxicology
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1007/s10565-026-10340-7
- Primary Topic
- Autophagy in Disease and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China